Mylan selling generic version of Pfizer's Detrol
PITTSBURGH (AP) — Mylan Inc. said Thursday that it is now selling a generic version of Pfizer Inc.'s overactive bladder drug Detrol.
The company said it started shipping its generic after receiving approval from the Food and Drug Administration. It said U.S. sales of Detrol, or tolterodine, totaled $61.5 million over the year ended Sept. 30.
Mylan plans to start selling a generic version of Detrol LA, a long-acting version of the drug, in early 2014 as part of an agreement with Pfizer. Annual U.S. sales of Detrol LA are around $600 million.
Shares of Pittsburgh-based Mylan rose 13 cents to $27.32 in midday trading after rising as high as $27.45 earlier in the session, its highest since October 2003.
Business Photo Galleriesview all
- 13061Oklahoma tornadoes: Plaza Towers Elementary School teacher shoved students into bathroom as wall collapsed
- 11652Oklahoma tornadoes: Cost, custom keep basements scarce
- 5853Oklahoma tornadoes: The 'Big Dog,' the little boy and the hug that triumphs over tragedy
- 5268Downtown wish list includes Super Target
- 4547OU softball: Sooners inspired by Casey Angle, run-rule Texas A&M
- 4352Finding Addyson – One family's struggle in the Moore tornado
- 4093Oklahoma City pastor will face trial in fatal shooting of son-in law